Pharmacological SciencesHydrochloric Acid
- A
- A For 10 x 106 to 50 106 spores per carrier b For 10 106 to 50 107 spores per carrier c For 10 105 to 50 106 spores per carrier
- A mixture of dehydrated alcohol and xylene
- Acetic Acid In Peptides
- Acid Value Free Fatty Acids
- Acidneutralizing Capacity
- Acoustic Emission Introduction
- Add the following - 2 3 4
- Adventitious And Endogenous Agent Detection
- Aerosols
- Amino Acid Analysis
- Analytical Methodology
- Ancillary Materials Residual Level Assessment And Removal
- Animal Tissue
- Anisidine Value
- Antibiotic Solids For Injection
- Antibioticsmicrobial Assays
- Antimicrobial Agentscontent
- Antimicrobial Effectiveness Testing
- Antimicrobial Preservative
- Ao
- AOther General Notices
- Apparatus - 2
- Apparatus And Diluents
- Apparatus And Glassware 3 4 5 6
- Apparatus Suitability
- Apparent Intrinsic Dissolutiondissolution Testing Procedures For Rotating Disk And Stationary Disk
- Appendix
- Definitions
- General Auditing Considerations
- Applicable Definitions
- Aqueous Solutions
- Articles of incorporation
- Assay For Ascorbic Acid
- Assay For Iodide
- ATITLE
- Au abCu
- Authority For Establishment And Release
- Automobiles
- B - 2
- Background
- Biological Tests
- Biotechnologyderived Articles
- Buffer Solutions For Standardization Of The Ph Meter
- Buffering Agent
- Bulk Density
- Bulk Density And Tapped Density
- Bulk Water
- C - 2
- C C
- Gui
- Calculation
- Calculations - 2
- Carbohydrate Determination
- Catgut And Other Surgical Sutures For Veterinarian
- Change to read
- Characteristic Production Processes
- Checklist For Acceptable Strength Quality And Purity
- Chemical Identification
- Chloride And Sulfate
- Chromatographic Method
- Chromatographic Methods
- Chromatographic Reagents
- Chromatography Introduction
- Clostridia
- Cm Vp 1 p3P3 P1
- Collaborative Study For The Evaluation Of A Usp Rs Candidate Material
- Column Chromatography
- Completeness Of Solution
- Component Selection Requirements
- Compounded Preparations
- Compounding Controls
- Compounding Environment
- Compounding Process
- Compounding Records And Documents
- Compounding Veterinarian Products
- Conclusion
- Constituted Solutions
- Containers and that contain active or inactive added substances except that the test for Weight Variation may be applied in the special cases stated in W3 below and
- Content Uniformity
- Content Uniformity Of Nitroglycerin Tablets
- Continued Suitability For Use Program
- Convolution
- Correlation Levels
- Criteria
- Criteria For Antimicrobial Effectiveness
- Crystallinity
- Cu Cs Auas
- D - 2
- D Solution D negative control of LAL Reagent Water
- Data Analysis
- Data Analysis And Interpretation
- Deconvolution
- Definition Of Terms - 2 - 2
- Delayedrelease Dosage Forms Not Accepted By The Japanese Pharmacopoeia
- Determination Of Maximum Valid Dilution
- Developing A Correlation
- Devices With Pathways Labeled Sterile
- Diagrams
- Differentiation
- Dimethylaniline
- Disposition Properties
- Diversity And Implications
- Dna
- Dna Determination
- Drug Compounding Equipment
- Drug Compounding Facilities
- Drug Release
- Dry Powder Inhalers
- Dvalue Determination
- Electrophoresis
- Emulsifying andor Solubilizing Agent
- Enumeration Methods
- Epianhydrotetracycline
- Ester Value
- Eukaryotic Cell Cultures
- Excipient Quality Systems
- Experimental Procedure
- Factors Affecting Measurement
- Fatty Acid Composition
- Flowers
- Foreign And Particulate Matter
- Fruits
- Functionality Tests
- Gas Chromatography
- Gelclot Techniques
- General Chapters
- General Considerations - 2 3
- General Gas Chromatographic Method
- General Guidance
- General Method For Pesticide Residues Analysis
- General Pharmacopeial Requirements
- General Principles
- General Procedure
- General Procedures - 2
- Glossary - 2
- Growth Promotion Test And Suitability Of The Counting Method
- H
- Harmonization Activities
- Hi - 2 3 4
- Highpressure Liquid Chromatography
- History - 2
- Horatio C Wood Charles Rice
- Human Blood And Bone Marrow
- Human Tissue
- Hydroxyl Value
- I
- Icp
- Icpaes
- Icpms
- Identification
- Identification Tetracyclines
- Identificationorganic Nitrogenous Bases
- Characterization Of The Expression System
- Iintroduction
- Iirationale For The Analysis Of The Expression Construct
- Immediaterelease Dosage Forms
- Immunoassays
- Impurity Reference Standards
- In titrant
- In Vitro And In Vivo Evaluation Of Dosage Forms
- In Vitro Evaluation
- In Vitroin Vivo Correlations
- In Vivo Evaluation Of Modifiedrelease Dosage Forms
- Info - 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111
- Infrared Absorption
- Ingredient Selection
- Ingredients
- Injected
- Inoculation And Dilution
- Instrument Specifications And Operating Parameters
- Instrumentation
- Interpretation - 2
- Interpretation Of Chromatograms
- Introduction - 2 3 4 5 6 7 8
- Iodine Value
- Ip
- Is achieved III
- Isolation
- J 100a
- Jo
- Krhmh
- Label Text
- Labeling
- Labels And Labeling
- Larger
- Leaves
- Legal Recognition
- Light Obscuration Particle Count Test
- Light Transmission Test
- Listing is representative but not exhaustive
- Locations
- M2
- Manufacturing Of Cell Therapy Products
- Manufacturing Overview
- Measurement
- Measurement Of Osmolality
- Measures Of Powder Compressibility
- Media
- Media And Diluents
- Medium - 2 3 4
- Members of the United States Pharmacopeial Convention as of June 30 2008
- Membrane Filtration
- Metereddose Inhalers
- Metereddose Inhalers And Dry Powder Inhalers
- Method 1 Light Obscuration Particle Count Test
- Method 2 Microscopic Particle Count Test
- Method I - 2 3 4 5 6
- Method I Titrimetric
- Method Idistillation Method
- Method Ii - 2 3 4 5 6
- Method Iigas Chromatographic Method
- Method - 2
- Method Iii Gravimetric
- Methods Of Analysis
- Methods Of Extraction
- Microscopic Particle Count Test
- ML
- Monoclonal antibodies Cellular receptors Dye Ligand Metal chelate
- Monoclonal Antibody Production
- Mostprobablenumber Method
- Multipleunit Containers And Unitdose Containers For Liquids
- Multipleunit Containers For Capsules And Tablets - 2
- N 554 tWh2
- Nasal Sprays
- Niacin Or Niacinamide Assay
- NL S2H2w2n
- Nomenclature
- Nomenclature And Definitions
- Not Accepted By The Japanese Pharmacopoeia
- NOTEFor Pseudomonas aeruginosa ATCC 25619 in the assay of Carbenicillin use 05 mL of a 125 dilution of the stock suspension per 100 mL of Medium
- Notice And Warning
- Ntu
- Observation And Interpretation Of Results
- Oils And Oily Solutions
- Ointments And Creams - 2
- Organisms And Inoculum
- Osmolality
- Osmolality And Osmolarity Introduction
- Osmolarity
- Osmotic Pressure
- Other Uspnf Related Publications
- Packaged Water
- Packaging - 2
- Packaging And Drug Preparation Containers
- Packaging And Storage Statement In Monographs
- Paper Chromatography
- Particle Size Distribution Estimation By Analytical Sieving
- Particulate Matter In Injections
- Particulate Matter In Ophthalmic Solutions
- Patient Counseling
- Peptide Mapping By Hplc
- Percolation Process
- Performance Evaluation
- Performance Testing
- Peroxide Value
- PH
- Pharmacodynamic Properties
- Pharmacokinetic Properties - 2
- Pharmacy Bulk Package
- Photometric Techniques
- Physicochemical Properties - 2
- Physicochemical Tests
- Plasma Spectrochemistry
- Platecount Methods
- Polarographic Method
- Preparation For Penicillins Or Cephalosporins
- Preparation Of Inoculum
- Preparation Of Specimen
- Preparation Of The Sample - 2 3
- Preparation Of The Standard
- Preparation of veterinary pharmaceuticals
- Preparations
- Prepare Solution A and positive product control Solution B using a dilution not greater than the MVD and treatments as directed in the Interfering Factors Test for the Gel Clot Techniques under Preparatory Testing for the Gel Clot Techniques Positive contro
- Principle
- Procedure
- Procedure For Bacitracin Neomycin And Polymyxin B
- Procedure For Temporary Mounts And Powdered Material - 2 3 4 5 6 7
- Procedures And Documentation
- Product Formulation
- Products Combined With Biocompatible Matrices
- Propellants
- Proper
- Protein A Quality Attributes Introduction
- Protein Content
- Protein Sequencing
- Pseudomonas aeruginosa
- Qualification - 2
- Qualification Of Ancillary Materials
- Quality Control - 2
- Quantitative Assays
- R
- Rabbit Blood Sugar Methodquantitative
- Radioactive Pharmaceuticals
- Recommended Solutions And Culture Media
- Records And Reports
- Recovery Of Microorganisms In The Presence Of Product
- Regulations Standards And New Methodologies
- Relationships With Other Standardssetting Organizations
- Responsibilities Of The Compounder
- Responsibility Of The Compounder
- Results And Interpretation
- Returns Of Pharmaceutical Articles From Patients Or Customers
- Risk Classification
- Roots
- Rules And Procedures
- Rules Procedures and Policies
- Safety Assessment Guidelines
- Safety Testsbiologicals
- Salmonella
- Sample Introduction
- Sample Preparation
- Sampling For Delivereddose Uniformity Of Metereddose Nasal Sprays
- Sampling The Delivered Dose From Dry Powder Inhalers
- Sampling The Delivered Dose From Metereddose Inhalers
- Saponification Value
- Sc bmP c
- Scope Of Biotechnology In The Development Of Pharmacopeial Articles
- Seeds
- Selection
- Sf
- Shipment From Manufacturer Or Wholesaler To Pharmacy
- Shipment From Manufacturer To Wholesaler
- Shipment From Pharmacy To Patient Or Customer
- Sieving Methods
- Singlesteroid Assay
- Sixmonth Implementation Guideline
- SN 0301JkySi S22 S32 S
- Solidification Temperature Of Fatty Acids
- Solids
- Solutions
- Solvent
- Special Handling
- Specified Variations To The General Method
- Stability Of Compounded Preparations
- Standard Preparation
- Steps In Establishing A Usp Reference Standard
- Sterile Devices
- Sterility - 2
- Sterility Tests
- Storage
- Suitability For Use And Purity Assignment
- Suturesdiameter
- Suturesneedle Attachment
- System Suitability
- T
- T2
- Tablet andor Capsule Diluent
- Tablet andor Capsule Lubricant
- Tablets
- Tapped Density
- Temperature Recording
- Terms And Definitions
- Test Animals
- Test For Aflatoxins
- Test For Pesticides
- Test For Sterility Of The Product To Be Examined
- Test Interpretation And Continuation
- Test Organisms
- Test Preparation
- Test Procedures
- Test Results
- Test Sieves
- Testing Of Products - 2
- Testing Practices And Procedures
- Than 20 of the average of the stated range
- The Assay
- The Peptide
- The Use Of Peptide Mapping For Genetic Stability Evaluation
- Theory And Terms
- Thermal Analysis
- Thinlayer Chromatography
- Topical Aerosols
- Total Oxidation Value Totox
- Total Viable Spore Count
- Training
- Transdermal Delivery Systemsgeneral Drug Release Standards
- Transfusion And Infusion Assemblies And Similar Medical Devices
- Types Of Biological Indicators
- Types Of Raw Materials
- Ultraviolet Absorption
- Ultraviolet Visible Infrared Atomic Absorption Fluorescence Turbidimetry Nephelometry And Raman Measurement
- Uniformity Of Dosage Units
- Units And Reference Standards
- Unsaponifiable Matter
- Use For Inprocess Validation
- Use Of Reference Standards
- Uses Of Usp Reference Standards
- Usp 32nf
- Usp Authenticated Reference Materials
- Usp32nf27
- Usp33nf28
- Uspnf Revision Process
- V
- Validation
- Validation Test
- Vi
- Vitamin B12 Activity Assay
- Vusp32
- Water And Sediment In Fixed Oils
- Water Conductivity
- Water Determination
- Weight Variation
- Wetting andor Solubilizing Agent
- Working Cell Bank WCB
- Wu Vucs Auas
- X
- 1
- Prq
- Y
